FIIs bought 1,07,00,000 shares: Multibagger Penny Stock Under Rs 5, Hit 52-Week High As Company Announces Business Expansion
The stock gave multibagger returns of 116 per cent from its 52-week low of Rs 1.55 per share.
Today, shares of Evexia Lifecare surged 3.33 per cent and made a new 52-week high of Rs 4.34 per share from its previous closing of Rs 3.95 on BSE. The stock gave multibagger returns of 116 per cent from its 52-week low of Rs 1.55 per share.
Evexia Lifecare Limited, through its subsidiary Evexia Lifecare Africa Limited, is expanding its reach into the United Arab Emirates healthcare market. They have signed a term sheet with ten UAE-based LLCs operating medical centres. These LLCs will be consolidated under a newly formed Special Purpose Vehicle (SPV). Evexia Lifecare Africa Limited will invest Rs 190 crore (AED 8.3 crore) for a 51 per cent stake in this SPV, giving them majority control. The remaining 49 per cent will be held by the existing partners of the LLCs. This investment will allow Evexia to tap into a growing healthcare market and offer a wider range of services through its newly acquired network of medical centres.
The combined revenue of the ten LLCs for the fiscal year 2022-2023 is Rs 278.8 crore. These medical centres offer a variety of specialities, including general medicine, surgery, cardiology, and dentistry. Evexia's investment will be used for capital expenditure to further expand the business of these centres. This move aligns with Evexia's mission of providing accessible and quality healthcare services.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
Additionally, Evexia Lifecare Limited has announced plans to acquire a 51 per cent stake in Vittal's MediCare Private Limited for Rs 35 crore. This acquisition will make Vittal's MediCare a subsidiary of Evexia Lifecare. Vittal's MediCare is a diagnostic center operating in India. This strategic acquisition aligns with Evexia's existing business in pharmaceuticals, chemicals, and lifecare products, offering potential synergies for growth. The transaction is expected to be completed within 45 days subject to necessary approvals.
Evexia Lifecare Limited formerly known as Kavit Industries Limited is engaged in the trading of chemicals, agricultural produce and various other products of consumer goods. The company has also formed a new subsidiary firm to set up pathology labs in Africa.
According to the financials, this FMCG company has a market cap of Rs 473 crore and reported positive numbers in its Quarterly Results (Q1FY25) and annual results (FY24). In Q1FY25, FIIs took a fresh entry & bought over 1 per cent stake or 1,07,00,000 shares in the company. Investors should keep an eye on this micro-cap stock under the radar.
Disclaimer: The article is for informational purposes only and not investment advice.